Home/Pipeline/ACD-301

ACD-301

Solid Tumors

PreclinicalLead Optimization

Key Facts

Indication

Solid Tumors

Phase

Preclinical

Status

Lead Optimization

Company

Advanced Cellular Dynamics

About Advanced Cellular Dynamics

Advanced Cellular Dynamics is pioneering a new class of engineered cellular therapeutics focused on immune modulation and targeted cancer treatment. The company's core technology enables precise control over cell fate and function, aiming to create more persistent and potent therapies. With a pipeline advancing through early clinical development, ACD is positioned at the forefront of the next wave of cell therapy innovation. The company is backed by leading life science investors and maintains strategic research collaborations with academic institutions.

View full company profile

Therapeutic Areas

Oncology Autoimmune Diseases Immunology

Other Solid Tumors Drugs

Drug	Company	Phase	Status
APVO603	Aptevo Therapeutics	Preclinical	Active
APVO711	Aptevo Therapeutics	Preclinical	Active
Platform-derived Immunotherapy	GenCirq	Pre-clinical	Active
DM001	Domabio	Phase 1	Active (IND cleared in US and China)
DM002	Domabio	Phase 1	Active (IND cleared in US)
DM005	Domabio	Phase 1	Active (IND cleared in US, Australia, and China; first patient dosed in US)
SP-2-225	Shuttle Pharmaceuticals	Preclinical	Candidate Lead
SP-1-161	Shuttle Pharmaceuticals	Preclinical	Candidate Lead
CAR-T Solid Tumor Program	Carina Biotech	Phase 1/2a	Active
HBM1020	Harbour BioMed	Phase 1	Active (Global)
HBM7022	Harbour BioMed	Phase 1	Out-Licensed
HBM9033	Harbour BioMed	Discovery	Out-Licensed